Bifogade filer
PDF
Kurs
-2,72%
Likviditet
0,23 MDKK
Kalender
| Est. tid* | ||
| 2025-11-27 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-28 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | N/A | Årsstämma |
| 2025-04-25 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-23 | - | Extra Bolagsstämma 2025 |
| 2025-04-11 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2024-11-21 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-02 | - | Extra Bolagsstämma 2024 |
| 2024-05-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-22 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2024-03-21 | - | Årsstämma |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2023-11-23 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-31 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2023-03-30 | - | Årsstämma |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | Årsstämma |
| 2022-03-25 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2022-02-24 | - | Bokslutskommuniké 2021 |
| 2021-11-25 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-01 | - | Extra Bolagsstämma 2021 |
| 2021-05-20 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-26 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2021-03-25 | - | Årsstämma |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-30 | - | Kvartalsrapport 2020-Q3 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Tuesday, 5 October 2021, is the last day of trading in warrants of series TO 1 on Spotlight Stock Market. The warrant TO 1 was issued in connection with Curasights A/S ("Curasight" or "the Company") IPO in 2020. The last day to subscribe for shares with the support of warrants of series TO 1 is 7 October 2021.
Warrants of series TO 1 that have not been subscribed for shares by Thursday 7 October 2021 or sold by Tuesday 5 October 2021 will expire and therefore be worthless. The warrant holder needs to take action and instruct their bank in due time, if not already done. It is solely the warrant holders' responsibility.
Application forms are available for download on Curasight's website (Curasight.com (https://www.curasight.com/investor/warrants-2021/)), Sedermera Fondkommission's website (Sedermera.se (https://sedermera.se/sv/uppdrag/2021-10/curasight-1)).
Sedermera Fondkommission
+46 40 - 615 14 10
info@sedermera.se
www.sedermera.se
For further information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: uk@curasight.com
www.curasight.com